ZIVO Bioscience Receives 1 Million Bridge Financing
| ZIVODelisted Stock | USD 1.81 0.01 0.55% |
About 62% of Zivo Bioscience's investor base is looking to short. The analysis of overall sentiment of trading Zivo Bioscience stock suggests that many investors are alarmed at this time. Zivo Bioscience's investing sentiment overview a quick insight into current market opportunities from investing in Zivo Bioscience. Many technical investors use Zivo Bioscience stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Zivo |
BLOOMFIELD HILLS, Mich., April 05, 2023--Zivo Bioscience, Inc. , a biotechagtech RD company engaged in the development of therapeutic, medicinal and nutritional product candidates derived from proprietary algal cultures, today announced a 1 million unsecured six-month loan from its Chairman, Chief Executive Officer, and President, John Payne. The loan carries 10 percent simple interest, may be prepaid without penalty, is extendable for an additional six months and inclu
Read at finance.yahoo.com
 |
Zivo Bioscience Fundamental Analysis
We analyze Zivo Bioscience's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Zivo Bioscience using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Zivo Bioscience based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Return On Equity
Return On Equity Comparative Analysis
Zivo Bioscience is currently under evaluation in return on equity category among its peers. Return on Equity or ROE tells company stockholders how effectually their money is being utilized or reinvested. It is a useful ratio when analyzing company profitability or the management effectiveness given the capital invested by the shareholders. ROE shows how efficiently a company utilizes investments to generate income.
Zivo Bioscience Potential Pair-trading
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Zivo Bioscience stock to make a market-neutral strategy. Peer analysis of Zivo Bioscience could also be used in its relative valuation, which is a method of valuing Zivo Bioscience by comparing valuation metrics with similar companies.
Peers
Zivo Bioscience Related Equities
| FBRX | Forte Biosciences | 9.70 | ||||
| CVKD | Cadrenal Therapeutics, | 7.35 | ||||
| KTTA | Pasithea Therapeutics | 6.55 | ||||
| FHTX | Foghorn Therapeutics | 2.57 | ||||
| IKNA | Ikena Oncology | 2.37 | ||||
| QNRX | Quoin Pharmaceuticals | 1.69 | ||||
| SNTI | Senti Biosciences | 0.93 | ||||
| RNXT | RenovoRx | 0.79 | ||||
| TPST | Tempest Therapeutics | 1.04 | ||||
| ERAS | Erasca | 2.05 |
Check out Your Current Watchlist to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Portfolio Comparator module to compare the composition, asset allocations and performance of any two portfolios in your account.
Other Consideration for investing in Zivo Stock
If you are still planning to invest in Zivo Bioscience check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Zivo Bioscience's history and understand the potential risks before investing.
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Stocks Directory Find actively traded stocks across global markets | |
| Commodity Directory Find actively traded commodities issued by global exchanges |